MELAS syndrome as a differential diagnosis of ischemic stroke;MELAS-syndrom als differenzialdiagnose des juvenilen ischämischen Insultes

Fortschritte der Neurologie Psychiatrie

Volumn 77, Issue 1, 2009, Pages 25-31

  Finsterer, J ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

Central nervous system; Encephalomyopathy; Metabolic disorder; Mitochondrial disorder; Stroke

Indexed keywords

ARGININE; BENZODIAZEPINE; CORTICOSTEROID; DICHLOROACETIC ACID; ETIRACETAM; LAMOTRIGINE; LEUCINE; NORPHENAZONE; PROSTAGLANDIN SYNTHASE; RIBOFLAVIN; SUCCINATE DEHYDROGENASE; THIAMINE; TOCOPHEROL; TRANSFER RNA; UBIQUINONE;

BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COGNITIVE DEFECT; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; GENE MUTATION; GENOTYPE; HEARING LOSS; HEART DISEASE; HUMAN; LACTIC ACIDOSIS; MELAS SYNDROME; MIGRAINE; MITOCHONDRION; MUSCLE BIOPSY; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHENOTYPE; PSYCHOSIS; RESPIRATORY CHAIN; REVIEW; SEIZURE; SHORT STATURE; STROKE; VISUAL IMPAIRMENT;

BIOPSY; BRAIN ISCHEMIA; DIAGNOSIS, DIFFERENTIAL; ELECTROPHYSIOLOGY; HUMANS; MAGNETIC RESONANCE IMAGING; MELAS SYNDROME; STROKE;

EID: 63649124202     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-2008-1100821     Document Type: Review

References (83)

1. Pavlakis SG, Phillips PC, DiMauro S et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16: 481-488
2. Bai RK, Wong LJ. Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach. Clin Chem 2004; 50: 996-1001
3. Oishi M, Miki K, Morita A et al. Mitochondrial encephalomyopathy associated with diabetes mellitus, cataract, and corpus callosum atrophy. Intern Med 2008; 47: 441-444
4. Choi BO, Hwang JH, Kim Jet al. A MELAS syndrome family harboring two mutations in mitochondrial genome. Exp Mol Med 2008; 40:354-360
5. Perez Lopez-Fraile MI, Barrena R, Montoya Jetal. Evolution until death of two members of a family with A3243G mutation and MELAS-phe-notype versus diabetes mellitus. Neurologia 2006; 21: 327-332
6. Deva R, Colville D, Savige J. Retinal atrophy associated with FSGS in a patient with MELAS-syndrome. Kidney Int 2008; 74: 252
7. Chen JC, Tsai TC, Liu CS et al. Acute hearing loss in a patient with mito-chondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes(MELAS). Acta Neurol Taiwan 2007; 16: 168- 172
8. Tan TM, Caputo C, Medici F et al. MELAS syndrome, diabetes and thyroid disease: the role of mitochondrial oxidative stress. Clin Endocrinol(Oxf) 2008;(in press)
9. Hsu PC, Chu CS, Lin THetal. Adult-onset hypertrophic cardiomyopathy manifested as initial major presentation of mitochondrial disease with A-to-G 3243 tRNA(Leu(UUR)) point mutation. Int J Cardiol 2007;(in press)
10. Sproule DM, Kaufmann P, Engelstad K et al. Wolff-Parkinson-White syndrome in Patients with MELAS. Arch Neurol 2007; 64: 1625-1627
11. WangW,SeakCJ,LiaoSCetal. Cardiac tamponade: a new complication in a patient with mitochondrial myopathy, encephalopathy, lactic aci-dosis, and strokelike episodes. Am J Emerg Med 2008; 26: 382.e1-2
12. Tay SH, Nordli JrDR, Bonilla E et al. Aortic rupture in mitochondrial en-cephalopathy, lactic acidosis, and stroke-like episodes. Arch Neurol 2006; 63: 281-283
13. Finsterer J, Stbllberger C, Schubert B. Acquired left ventricular hypertra-beculation/ noncompaction in mitochondriopathy. Cardiology 2004;102: 228-230
14. Betts J, Barron MJ, Needham SJ et al. Gastrointestinal tract involvement associated with the 3243A>G mitochondrial DNA mutation. Neurology 2008; 70: 1290-1292
15. Chiyonobu T, Noda R, Yoshida M et al. Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic aci-dosis, and stroke-like episodes(MELAS) associated with phenytoin therapy. Brain Dev 2008; 30: 430-433
16. Iizuka T, Sakai F, Suzuki N et al. Neuronal hyperexcitability in strokelike episodes of MELAS syndrome. Neurology 2002; 59: 816-824
17. Iizuka T, Sakai F, Kan S et al. Slowly progressive spread of the stroke like lesions in MELAS. Neurology 2003; 61: 1238-1244
18. Pronicki M, Sykut-Cegielska J, Mierzewska H et al. Diversity of clinical symptoms in A3243G mitochondrial DNA mutation(MELAS-syn-drome mutation). Med Sci Monit 2002; 8: CR767- 773
19. Carmi E, Defossez C, Morin G et al. MELAS-syndrome(mitochondrial encephalopathy with lactic acidosis and stroke-like episodes. Ann Dermatol Venereol 2001; 128: 1031-1035
20. Strachan J, McLellan A, Kirkpatrick M et al. Ketoacidosis: an unusual presentation of MELAS. J Inherit Metab Dis 2001; 24: 409-410
21. Ohkoshi N, Ishii A, Shiraiwa N et al. Dysfunction of the hypothalamic-pituitary system in mitochondrial encephalomyopathies. J Med 1998;29: 13-29
22. Iizuka T, Sakai F, Ide Tet al. Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in ME-LAS-implication of neurovascular cellular mechanism. J Neurol Sci 2007; 257: 126- 138
23. Feng F, You H, Gao J etal. Evaluation of mitochondrial encephalomyo-pathy with lactic acidosis and stroke-like episodes with magnetic resonance imaging and proton magnetic resonance spectroscopy. Chin Med Sci J2006; 21: 234- 238
24. Bi WL, Baehring JM, Lesser RL. Evolution of brain imaging abnormalities in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes. J Neuroophthalmol 2006; 26: 251-256
25. Longo N, Schrijver I, Vogel H et al. Progressive cerebral vascular degeneration with mitochondrial encephalopathy. Am J Med Genet A 2008;146: 361-367
26. Scaglia F, Wong LJ, Vladutiu GD et al. Predominant cerebellar volume loss as a neuroradiologic feature of pediatric respiratory chain defects. AmJNeuroradiol2005; 26: 1675-1680
27. GeldofK, Ramboer K, Goethals JM et al. CT and MRI appearance of mitochondrial encephalopathy. JBR-BTR 2007; 90: 288-289
28. Apostolova LG, White M, Moore SA et al. Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS. Arch Neurol 2005; 62: 1154- 1156
29. Chung SH, Chen SC, Chen WJ et al. Symmetric basal ganglia calcification in a 9-year-old child with MELAS. Neurology 2005; 65: E19
30. Jian-Ren L. Precipitation of stroke-like event by chickenpox in a child with MELAS-syndrome. Neurol India 2005; 53: 323- 325
31. Ohama E, Ohara S, Ikuta F et al. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropa-thol 1987; 74: 226- 233
32. Sakuta R, Nonaka et al. Vascular involvement in mitochondrial myopathy. Ann Neurol 1989; 25: 594-601
33. Takahashi N, Shimada T, Murakami Yet al. Vascular involvement in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Am J Med Sci 2005; 329: 265-266
34. Gilchrist JM, Sikirica M, Stopa E et al. Adult-onset MELAS. Evidence for involvement of neurons as well as cerebral vasculature in strokelike episodes. Stroke 1996; 27: 1420-1423
35. Ito H, Mori K, Harada M et al. Serial brain imaging analysis of strokelike episodes in MELAS. Brain Dev 2008; 30: 483-488
36. Molnar MJ, Valikovics A, Molnar Setal. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 2000; 55: 544-548
37. Nariai T, Ohno K, Akimoto H et al. Cerebral blood flow, vascular response and metabolism in patients with MELAS syndrome-xenon CT and PET study. KeioJ Med 2000; 49(suppl 1): A68-70
38. Sakuta R, Honzawa S, Murakami N et al. Atypical MELAS associated with mitochondrial tRNA(Lys) gene A8296G mutation. Pediatr Neurol 2002; 27: 397-400
39. Wong LJ, Yim D, Bai RK et al. A novel mutation in the mitochondrial tRNA(Ser(AGY)) gene associated with mitochondrial myopathy, ence-phalopathy, and complex I deficiency. J Med Genet 2006; 43: e46
40. Mizukami K, Sasaki M, Suzuki Tet al. Central nervous system changes in mitochondrial encephalomyopathy: light and electron microscopic study.ActaNeuropathol 1992; 83:449-452
41. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyo-pathies. Nature 1990; 348: 651-653
42. Chou HF, Liang WC, Zhang Qet al. Clinical and genetic features in a ME-LAS-child with a 3271T>C mutation. Pediatr Neurol 2008; 38: 143-146
43. Tzoulis C, BindoffLA.Melas associated with mutations in the polg1 gene. Neurology 2008; 70: 1054
44. Shanske S, Coku J, Lu J et al. The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. Arch Neurol 2008; 65: 368-372
45. Hirata K, Akita Y, Povalko N et al. Effect of L-arginine on synaptosomal mitochondrial function. Brain Dev 2008; 30: 238-245
46. Koga Y, Akita Y, Nishioka Jet al. MELAS and L-arginine therapy. Mitochondrion 2007; 7: 133-139
47. Koga Y, Akita Y, Junko N et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 2006; 66: 1766-1769
48. Koga Y, Akita Y, Nishioka Jet al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005; 64: 710- 712
49. Koga Y,Ishibashi M, Ueki Ietal. Effects of L-arginine on the acute phase of strokes in three patients with MELAS. Neurology 2002; 58: 827-828
50. Kubota M, Sakakihara Y, Mori Metal. Beneficial effect of L-arginine for stroke-like episode in MELAS. Brain Dev 2004; 26: 481-483
51. Sproule DM, Dyme J, Coku Jet al. Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA((Leu)) gene(m.3243A>G). J Inherit Metab Dis 2008;(in press)
52. Nakano K, Tarashima M, Tachikawa E et al. Platelet mitochondrial evaluation during cytochrome c and dichloroacetate treatments of MELAS. Mitochondrion 2005; 5: 426-433
53. Maeda K, Tatsumi M, Tahara M et al A case of stroke-like episode of MELAS of which progressive spread would be prevented by edara-vone. Rinsho Shinkeigaku 2005; 45: 416-421
54. Maruyama S, Yamada T, Ishimoto Yet al. A case of MELAS showing CSF pleocytosis associated with stroke-like episodes. Rinsho Shinkeigaku 1998; 38: 641-644
55. Ramaekers VT, Weis J, Sequeira JM et al. Mitochondrial complex I ence-phalomyopathy and cerebral 5-methyltetrahydrofolate deficiency. Neuropediatrics 2007; 38: 184-187
56. Stacpoole PW, Gilbert LR, Neiberger RE et al. Evaluation of long-term treatment of children with congenital lactic acidosis with dichloro-acetate. Pediatrics 2008; 121: e1223-e1228
57. Inoue S, Nagayama M, Aoki H et al. Continuous venovenous hemodia-filtration for life-threatening mitochondrial myopathy with lactic aci-dosis and rhabdomyolysis. J Intensive Care Med 2007; 22: 240-244
58. Thomas JE, Lee N, Thompson PD. Statins provoking MELAS syndrome. A case report. Eur Neurol 2007; 57: 232-235
59. Lin CM, Thajeb P. Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA. Metab Brain Dis 2007; 22: 105-109
60. Carroll MB.MELAS masquerading as a systemic vasculitis. J Clin Rheumatol 2007; 13: 334-337
61. Patel IB, Sidani M, Zoorob R.Mitochondrial encephalopathy, lactic aci-dosis and stroke-like syndrome(MELAS): a case report, presentation, and management. South Med J2007; 100: 70- 72
62. Lindberg C, MoslemiAR, OldforsA.MELAS syndrome in a patient with a point mutation in MTTS1. Acta Neurol Scand 2008; 117: 128-132
63. Nakagaki H, Furuya J, Santa Yet al. A case of MELAS presenting juvenile-onset hyperglycemic chorea-ballism. Rinsho Shinkeigaku 2005;45: 502-505
64. HenningF, Oey PL, Oerlemans WG et al. Small-fiber neuropathy and the 3243A>G mutation in mitochondrial DNA. J Neurol 2007; 254: 1281-1282
65. Balestri P, Grosso S.Endocrine disorders in two sisters affected by MELAS syndrome. J Child Neurol 2000; 15: 755-758
66. Morten KJ, Cooper JM, Brown GKet al. A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 1993; 2:2081-2087
67. Vydt TC, de Coo RF, Soliman OI et al. Cardiac involvement in adults with m.3243A>G MELAS gene mutation. Am J Cardiol 2007; 99: 264-269
68. Nishioka J, Akita Y, Yatsuga S et al. Inappropriate intracranial hemody- namics in the natural course of MELAS. Brain Dev 2008; 30: 100-105
69. Menotti F, Brega A, Diegoli M et al. A novel mtDNA point mutation in tRNA(Val) is associated with hypertrophic cardiomyopathy and MELAS. Ital Heart J 2004; 5: 460-465
70. Sweeney MG, Bundey S, Brockington M et al. Mitochondrial myopathy associated with sudden death in young adults and a novel mutation in the mitochondrial DNA leucine transfer RNA(UUR) gene. Q J Med 1993; 86: 709-713
71. Jeppesen TD, Schwartz M, Hansen Ket al. Late onset of stroke-like episode associated with a 3256C->int mutation of mitochondrial DNA. J Neurol Sci 2003; 214: 17-20
72. Goto Y, Nonaka I, Horai S. A new mtDNA mutation associated with mi-tochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes(MELAS). Biochim Biophys Acta 1991; 1097: 238-240
73. MalfattiE, BugianiM, Invernizzi Fet al. Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy. Brain 2007; 130: 1894-1904
74. Kirby DM, McFarland R, OhtakeAetal. Mutations of the mitochondrial ND1 gene asacause of MELAS. J Med Genet 2004; 41: 784-789
75. Rossmanith W, FreilingerM, Roka J et al. Isolated cytochrome c oxidase deficiency as a cause of MELAS. J Med Genet 2008; 45: 117-121
76. Lertrit P, Noer AS, Jean-Francois MJetal. A new disease-related mutation for mitochondrial encephalopathy lactic acidosis and strokelike episodes(MELAS) syndrome affects the ND4 subunit of the respiratory complex I. Am J Hum Genet 1992; 51: 457-468
77. Abu-Amero KK, Ozand PT, Al-Dhalaan H. Novel mitochondrial DNA transversion mutation in transfer ribonucleic acid for leucine 2(CUN) in a patient with the clinical features of MELAS. J Child Neurol 2006; 21: 971-972
78. Liolitsa D, Rahman S, Benton S et al. Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations? Ann Neurol 2003; 53: 128-132
79. Naini AB, LuJ, Kaufmann Petal. Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Arch Neurol 2005; 62:473-476
80. Crimi M, Galbiati S, Moroni I et al. A missense mutation in the mito-chondrial ND5 gene associated with a Leigh-MELAS overlap syndrome. Neurology 2003; 60: 1857-1861
81. Santorelli FM, Tanji K, Kulikova R et al. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem BiophysRes Commun 1997; 238: 326-328
82. Vanniarajan A, Nayak D, Reddy AG et al. Clinical and genetic uniqueness in an individual with MELAS. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 440-444
83. Deschauer M, Tennant S, Rokicka Aetal. MELAS associated with mutations in the POLG1 gene. Neurology 2007; 68: 1741-1742